FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Prednisoloneprednisolone oral | Prednisolone 15 mg/5mL | SolutionOral | TRUPHARMA, LLC | Aug 4, 2026 | 52817-860 |
| Valproic Acid | Valproic acid 250 mg/5mL | SolutionOral | American Health Packaging | Aug 4, 2026 | 60687-942 |
| Valproic Acid | Valproic acid 500 mg/10mL | SolutionOral | American Health Packaging | Aug 4, 2026 | 60687-953 |
| Hydroxyzine hydrochloride | Hydroxyzine hydrochloride 10 mg/1 | TabletOral | Coupler LLC | Aug 4, 2026 | 67046-0833 |
| prazosin hydrochloride | Prazosin hydrochloride 5 mg/1 | CapsuleOral | Coupler LLC | Aug 4, 2026 | 67046-1050 |
| Gabapentin | Gabapentin 600 mg/1 | TabletOral | Coupler LLC | Aug 4, 2026 | 67046-1086 |
| Ciprofloxacin Hydrochloride | Ciprofloxacin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Coupler LLC | Aug 4, 2026 | 67046-1692 |
| Montelukast | Montelukast sodium 10 mg/1 | TabletOral | Coupler LLC | Aug 4, 2026 | 67046-2060 |
| Fenofibrate | Fenofibrate 54 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | Aug 4, 2026 | 70518-4721 |
| Fluvoxamine maleate extended-release | Fluvoxamine maleate 100 mg/1 | Capsule, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | Aug 4, 2026 | 70710-1847 |
| Fluvoxamine maleate extended-release | Fluvoxamine maleate 150 mg/1 | Capsule, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | Aug 4, 2026 | 70710-1848 |
| Indocyanine green | — | Kit | Zydus Pharmaceuticals USA Inc. | Aug 4, 2026 | 70710-2018 |
| Fluvoxamine maleate extended-release | Fluvoxamine maleate 100 mg/1 | Capsule, Extended releaseOral | Zydus Lifesciences Limited | Aug 4, 2026 | 70771-1957 |
| Fluvoxamine maleate extended-release | Fluvoxamine maleate 150 mg/1 | Capsule, Extended releaseOral | Zydus Lifesciences Limited | Aug 4, 2026 | 70771-1958 |
| Indocyanine Green | — | Kit | Zydus Lifesciences Limited | Aug 4, 2026 | 70771-1961 |
| Rifadinrifampicin | — | Kit | Sanofi-Aventis U.S. LLC | Aug 3, 2026 | 0068-0660 |
| Awiqliinsulin icodec-abae | Insulin icodec 700 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | Aug 3, 2026 | 0169-3105 |
| Valproic Acid | Valproic acid 250 mg/5mL | SolutionOral | Major Pharmaceuticals | Aug 3, 2026 | 0904-7620 |
| Valproic Acid | Valproic acid 500 mg/10mL | SolutionOral | Major Pharmaceuticals | Aug 3, 2026 | 0904-7621 |
| Pregabalin | Pregabalin 25 mg/1 | CapsuleOral | Unichem Pharmaceuticals (USA), Inc. | Aug 3, 2026 | 29300-439 |
| Pregabalin | Pregabalin 50 mg/1 | CapsuleOral | Unichem Pharmaceuticals (USA), Inc. | Aug 3, 2026 | 29300-440 |
| Pregabalin | Pregabalin 75 mg/1 | CapsuleOral | Unichem Pharmaceuticals (USA), Inc. | Aug 3, 2026 | 29300-441 |
| Pregabalin | Pregabalin 100 mg/1 | CapsuleOral | Unichem Pharmaceuticals (USA), Inc. | Aug 3, 2026 | 29300-442 |
| Pregabalin | Pregabalin 150 mg/1 | CapsuleOral | Unichem Pharmaceuticals (USA), Inc. | Aug 3, 2026 | 29300-443 |
| Pregabalin | Pregabalin 200 mg/1 | CapsuleOral | Unichem Pharmaceuticals (USA), Inc. | Aug 3, 2026 | 29300-444 |